Attribution of posttransplantation toxicity to methotrexate regarding genotype of methylenetetrahydrofolate reductase gene (MTHFR) polymorphism needs further clarification.
Matsuo
K
K
Suzuki
R
R
Morishima
Y
Y
Hamajima
N
N
D005838:Genotype; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000633:toxicity*; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D009061:Mouth Mucosa / Q000382:microbiology; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics*; D011110:Polymorphism, Genetic; D013280:Stomatitis / Q000139:chemically induced
D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008727:Methotrexate